Rapid responses are electronic comments to the editor. They enable our users
to debate issues raised in articles published on bmj.com. A rapid response
is first posted online. If you need the URL (web address) of an individual
response, simply click on the response headline and copy the URL from the
browser window. A proportion of responses will, after editing, be published
online and in the print journal as letters, which are indexed in PubMed.
Rapid responses are not indexed in PubMed and they are not journal articles.
The BMJ reserves the right to remove responses which are being
wilfully misrepresented as published articles or when it is brought to our
attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not
including references and author details. We will no longer post responses
that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
Although the subtitle of the recent editorial on Whooping cough 1
referred to “countries with high vaccination rates and low mortality”, the
authors offered little practical advice to doctors in such countries, eg
the UK and Australia, as how to currently tackle this re-emerging
condition. It is precisely because these are developed countries that
affected parents or the community, as a whole does not readily accept even
a “low” mortality from infection.
England and Wales had achieved a vaccination uptake of over 80% in
1972, only to see this fall to about 30% in 1975 because of public anxiety
about the vaccine’s safety 2, (sparked by a member of our own profession,
as with the current scare about the safety of MMR vaccine).
It did not need a genius to have anticipated that in the UK one would
see a cohort of children many of whom were neither vaccinated nor
naturally infected with pertussis. This cohort is now of the age to become
/ have become young mothers and fathers.
There are now pertussis vaccines that are suitable for use in adults
3. Is it not unreasonable to consider including pertussis serology as
part of antenatal screening, and offer vaccination to susceptible
mothers,(and fathers)? They after all, will in the main be the chief
caregivers to their infants during their vulnerable “window period”,
between birth and protection after their vaccination course—with infection
at this age carrying the greatest risk of death or critical illness.
Of course other people might infect them, but at present one can only
re-emphasise the old message-“coughs and sneezes spread diseases”.
Medical interventions today require cost benefit analysis, and be
evidence based. It should be possible to conduct a randomised controlled
trial of this strategy between different hospital and primary health care
trusts.
David S G Sloan
Epidemiologist
Central Public Health Unit Rockhampton,
PO Box 946, Rochampton,
Queensland 4700,
Australia
1 Crowcroft N S, Britto J. Whooping cough-a continuing problem. BMJ
2002; 324: 1537-8.(29 June.)
2 Department of Health. Immunisation against Infectious Disease.
London. Her Majesty’s Stationary Office,1996.
3 Wirsing von Konig CH, Postels-Multani S, Block H L, Schimitt H J.
Pertussis in adults: frequency of transmission after household exposure.
Lancet 1995;
346:1326-9.
(ps- the "o" of Konig has an umlaut.)
Competing interests:
No competing interests
01 July 2002
David S Sloan
Epidemiologist
Central Public Health Unit Rockhampton, PO Box 946, Rockhampton, Queensland, 4700, Australia
Act now to prevent pertussis in young infants
Sir,
Although the subtitle of the recent editorial on Whooping cough 1
referred to “countries with high vaccination rates and low mortality”, the
authors offered little practical advice to doctors in such countries, eg
the UK and Australia, as how to currently tackle this re-emerging
condition. It is precisely because these are developed countries that
affected parents or the community, as a whole does not readily accept even
a “low” mortality from infection.
England and Wales had achieved a vaccination uptake of over 80% in
1972, only to see this fall to about 30% in 1975 because of public anxiety
about the vaccine’s safety 2, (sparked by a member of our own profession,
as with the current scare about the safety of MMR vaccine).
It did not need a genius to have anticipated that in the UK one would
see a cohort of children many of whom were neither vaccinated nor
naturally infected with pertussis. This cohort is now of the age to become
/ have become young mothers and fathers.
There are now pertussis vaccines that are suitable for use in adults
3. Is it not unreasonable to consider including pertussis serology as
part of antenatal screening, and offer vaccination to susceptible
mothers,(and fathers)? They after all, will in the main be the chief
caregivers to their infants during their vulnerable “window period”,
between birth and protection after their vaccination course—with infection
at this age carrying the greatest risk of death or critical illness.
Of course other people might infect them, but at present one can only
re-emphasise the old message-“coughs and sneezes spread diseases”.
Medical interventions today require cost benefit analysis, and be
evidence based. It should be possible to conduct a randomised controlled
trial of this strategy between different hospital and primary health care
trusts.
David S G Sloan
Epidemiologist
Central Public Health Unit Rockhampton,
PO Box 946, Rochampton,
Queensland 4700,
Australia
1 Crowcroft N S, Britto J. Whooping cough-a continuing problem. BMJ
2002; 324: 1537-8.(29 June.)
2 Department of Health. Immunisation against Infectious Disease.
London. Her Majesty’s Stationary Office,1996.
3 Wirsing von Konig CH, Postels-Multani S, Block H L, Schimitt H J.
Pertussis in adults: frequency of transmission after household exposure.
Lancet 1995;
346:1326-9.
(ps- the "o" of Konig has an umlaut.)
Competing interests: No competing interests